Developing research priorities for palliative care in Colombia: a priority setting partnership approach.

BACKGROUND: A recent Lancet commission called for more research on palliative care in low- and middle-income (LMIC) countries such as Colombia. A research priority setting approach has been recommended by The Global Forum for Health Research to address the huge gap in research output between LMIC and high-income countries, with influential health service bodies recommending the active involvement of non-research expert stakeholders in establishing research priorities to address service user needs. METHOD: Priority setting partnership (PSP) following the four stages of the James Lind Alliance methodology; establishing the partnership, identifying evidence uncertainties, refining questions and uncertainties, and prioritization. Data from MS forms were analysed using descriptive statistics. RESULTS: A total of 33 stakeholders attended an online PSP workshop and completed the Mentimeter exercise in Microsoft Teams. A total of 48 attended the subsequent in person prioritisation exercise in urban Bogota (n = 22) and rural Popayan (n = 25). The stakeholders were a diverse group of health professionals (physicians, medical students, nurses, dentists, physiotherapists, nutritionist, occupational and speech therapists), financial and administrative staff and patients with life-limiting illness and caregivers. Top research priorities included patient and caregiver needs, service provider education and training, and better integration of palliative care with cancer and non-cancer services. The key challenges included a lack of interest in palliative care research, along with funding, time and resource constraints. Key solutions included collaboration across disciplines and settings, highlighting benefits of palliative research to help secure adequate resources, and multicentre, mixed method research, with patient involvement from the research development stage. CONCLUSION: The findings of this PSP should be disseminated among palliative care associations worldwide to inform international multicentre studies, and among governmental and nongovernmental organisations that promote research in Colombia. A focus on patient and family caregiver palliative care needs in Colombia should be prioritised.

Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life.

Background: Post-acute sequelae of SARS-CoV-2, referred to as "long COVID", are a globally pervasive threat. While their many clinical determinants are commonly considered, their plausible social correlates are often overlooked. Methods: Here, we use data from a multinational prospective cohort study to compare social and clinical predictors of differences in quality of life with long COVID. We further measure the extent to which clinical intermediates may explain relationships between social variables and quality of life with long COVID. Findings: Beyond age, neuropsychological and rheumatological comorbidities, educational attainment, employment status, and female sex were important predictors of long COVID-associated quality of life days (long COVID QALDs). Furthermore, most of their associations could not be attributed to key long COVID-predicting comorbidities. In Norway, 90% (95% CI: 77%, 100%) of the adjusted association between belonging to the top two quintiles of educational attainment and long COVID QALDs was not explained by these clinical intermediates. The same was true for 86% (73%, 100%) and 93% (80%,100%) of the adjusted association between full-time employment and long COVID QALDs in the United Kingdom (UK) and Russia. Additionally, 77% (46%,100%) and 73% (52%, 94%) of the adjusted associations between female sex and long COVID QALDs in Norway and the UK were unexplained by the clinical mediators. Interpretation: Our findings highlight that socio-economic proxies and sex are key predictors of long COVID QALDs and that other (non-clinical) mechanisms drive their observed relationships. Importantly, we outline a multi-method, adaptable causal approach for evaluating the isolated contributions of social disparities to experiences with long COVID. Funding: UK Foreign, Commonwealth and Development Office; Wellcome Trust; Bill & Melinda Gates Foundation; Oxford COVID-19 Research Response Funding; UK National Institute for Health and Care Research; UK Medical Research Council; Public Health England; Liverpool Experimental Cancer Medicine Centre; Research Council of Norway; Vivaldi Invest A/S; South Eastern Norway Health Authority.

What are the effects of drugs for nausea and vomiting prevention following general anesthesia? Summary and comments regarding a Cochrane Collaboration network meta-analysis

The aim of this special article is to summarize and discuss, from an anesthesia perspective, the network meta-analysis on drugs used for the prevention of postoperative nausea and vomiting after general anesthesia, in agreement with the Cochrane Colombia collaboration and within the framework of the Cochrane Corners strategy. Through the combination of indirect comparisons and based on the evidence, the use of aprepitant, ramosetron, granisetron, dexamethasone and ondansetron is recommended with a high degree of certainty for the reduction of postoperative nausea and vomiting.

Este artículo especial tiene el objetivo de resumir y discutir desde la perspectiva de la anestesiología, el metaanálisis en red sobre fármacos para prevenir náuseas y vómito posoperatorio luego de anestesia general, en acuerdo con la colaboración Cochrane Colombia y en el marco de la estrategia Cochrane Corners. Mediante la combinación de la evidencia y el uso de comparaciones indirectas, se ha recomendado con alto grado de certeza el uso de aprepitant, ramosetrón, granisetrón, dexametasona y ondansetrón para la reducción de náuseas y vómito posoperatorio.

How many people need palliative care for cancer and non-cancer diseases in a middle-income country? Analysis of mortality data / ¿Cuántas personas requieren cuidados paliativos para enfermedades oncológicas y no oncológicas en un país de ingresos medios? Análisis de datos de mortalidad

Abstract Introduction: Aging of the population and the accompanying increase in prevalence of chronic illnesses mean that more people will need palliative care. This need has not been extensively quantified in middle-income countries to policy planning and expanding health care. Objective: Provide an estimate of the need of palliative care services in Colombia and compare these needs with the current available offer. Methods: Cross-sectional study based on mortality statistics for Colombia for the period 2012 to 2016. We calculated age-specific and sex-specific numbers of deaths and mortality rates from death certificate for defined chronic illnesses to estimate the prevalence of palliative care need in Colombia, and contrasted this information with the current offer according to the Colombian Observatory of Palliative Care. Results: The numbers of deaths requiring palliative care increased from 107,065 in 2012 to 128,670 in 2016 (61.2% of total deaths). The causes of these deaths vary by age group, with a clearly more important proportion of heart and cerebrovascular diseases and dementia in advances ages, and HIV/AIDS in young ages. In all age groups, malignant neoplasms are an important part of the causes of deaths of those requiring palliative care (31.3% of all deaths in 2016). Contrasting this needs, in most areas there is no or very limited offer of palliative care services. Conclusion: A real palliative care policy, including a vast increase in training opportunities in the field and regulation allowing a wide range of health practitioners to be involved in palliative care, is necessary in Colombia to improve the palliative care offer.

Resumen Introducción: El envejecimiento de la población y el consecuente aumento en la prevalencia de enfermedades crónicas implica que habrá más personas que necesitarán cuidados paliativos. Esta necesidad no se ha cuantificado mayormente en los países de medianos ingresos con miras a la planificación de políticas y a la ampliación de la atención en salud. Objetivo: Ofrecer un estimado de la necesidad de servicios de cuidados paliativos en Colombia y comparar dichas necesidades con la oferta disponible en la actualidad. Métodos: Estudio transversal basado en estadísticas de mortalidad en Colombia para el periodo comprendido entre 2012-2016. Calculamos las cifras de muertes y tasas de mortalidad específicas por edad y sexo a partir de los certificados de defunción correspondientes a enfermedades crónicas definidas, a _n de estimar la prevalencia de la necesidad de cuidados paliativos en Colombia, y se comparó dicha información con la oferta actual, de acuerdo con el Observatorio Colombiano de Cuidados Paliativos. Resultados: Las cifras correspondientes a muertes que requirieron cuidados paliativos aumentaron de 107 065 en el 2012 a 128 670 en el 2016 (61.2% del total de muertes). Las causas de estas muertes varían según el grupo etario, con un porcentaje evidentemente mayor de enfermedades cardiacas, cerebrovasculares y demencia en edades avanzadas, y VIH/SIDA en los grupos más jóvenes. En todos los grupos etarios, las neoplasias malignas son una parte importante de las causas de muerte de quienes requieren cuidados paliativos (31.3% de todas las muertes en el 2016). Estas necesidades contrastan con el hecho de que en la mayoría de las áreas no existen servicios de cuidados paliativos, o su oferta es muy limitada. Conclusiones: En Colombia se necesita una verdadera política de cuidados paliativos, incluyendo un aumento significativo de las oportunidades de capacitación en el área, así como un marco regulatorio que permita que una amplia gama de profesionales de la salud participen en cuidados paliativos, a in de mejorar la oferta de estos servicios.